Herpes simplex virus encephalitis in Peru: A multicentre prospective study

S. M. Montano, N. Mori, C. A. Nelson, T. G.N. Ton, V. Celis, E. Ticona, M. Sihuincha, D. H. Tilley, T. Kochel, J. R. Zunt

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

6 Citas (Scopus)


Herpes simplex virus (HSV) is one of the most commonly identified infectious aetiologies of encephalitis in North America and Europe. The epidemiology of encephalitis beyond these regions, however, is poorly defined. During 2009-2012 we enrolled 313 patients in a multicentre prospective study of encephalitis in Peru, 45 (14·4%) of whom had confirmed HSV infection. Of 38 patients with known HSV type, 84% had HSV-1 and 16% had HSV-2. Patients with HSV infection were significantly more likely to present in the summer months (44·4% vs. 20·0%, P = 0·003) and have nausea (60·0% vs. 39·8%, P = 0·01) and rash (15·6% vs. 5·3%, P = 0·01) compared to patients without HSV infection. These findings highlight differences in the epidemiology and clinical presentation of HSV encephalitis outside of the Northern Hemisphere that warrant further investigation. Furthermore, there is an urgent need for improved HSV diagnostic capacity and availability of intravenous acyclovir in Peru.
Idioma originalInglés estadounidense
Páginas (desde-hasta)1673-1678
Número de páginas6
PublicaciónEpidemiology and Infection
EstadoPublicada - 1 jun. 2016


Profundice en los temas de investigación de 'Herpes simplex virus encephalitis in Peru: A multicentre prospective study'. En conjunto forman una huella única.

Citar esto